Qube Research & Technologies LTD Tandem Diabetes Care Inc Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 42,193 shares of TNDM stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,193Holding current value
$1.27 Million% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding TNDM
# of Institutions
360Shares Held
72.5MCall Options Held
3.36MPut Options Held
229K-
Black Rock Inc. New York, NY11.1MShares$335 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.36MShares$222 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA3.27MShares$98.4 Million0.02% of portfolio
-
State Street Corp Boston, MA2.66MShares$80.1 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.39MShares$72 Million1.44% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $1.94B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...